Back to results
US 9,314,444 B2Granted
Composition and method for treatment of NASH
AssigneeBioKier, Inc.
InventorJerzy Ryszard Szewczyk
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treating NASH or NAFLD by delivery of an effective amount of a composition comprising L-glutamine or butyric acid formulated for release in the colon by bypassing the upper digestive tract and stomach.
Claims10
A method of treating NASH or NAFLD comprising:
- a) selecting a composition comprising a composition from the group consisting of L-glutamine, the composition formulated to release in a colon-targeted delivery system;
- and
- b) administering the L-glutamine composition to the individual sufficient to achieve the desired result, wherein the L-glutamine is administrated to the individual at a daily dosage of 0.3 to 30 mg/kg of body weight.
A method of treating NASH or NAFLD comprising:
- a) selecting a composition comprising a composition from the group consisting of butyric acid, the composition formulated to release in a colon-targeted delivery system or in a rectal release system;
- and
- b) administering the butyric acid composition to the individual sufficient to achieve the desired result, wherein the butyric acid is administrated to the individual at a daily dosage of 0.3 to 30 mg/kg of body weight.
Dependencies are inferred from the claim text.